Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-01-23 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award +1,412 42,695
2019-01-23 FOEHR MATTHEW W President and COO Grant or award +3,547 116,934
2019-01-23 FOEHR MATTHEW W President and COO Shares withheld for taxes −1,284 $111.78 $144K 115,650
2019-01-23 FOEHR MATTHEW W President and COO Grant or award +3,715 119,365
2019-01-23 FOEHR MATTHEW W President and COO Shares withheld for taxes −1,284 $111.78 $144K 118,081
2019-01-23 HIGGINS JOHN L Chief Executive Officer Grant or award +7,256 126,465
2019-01-23 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −3,597 $111.78 $402K 122,868
2019-01-23 HIGGINS JOHN L Chief Executive Officer Grant or award +6,390 129,258
2019-01-23 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −3,168 $111.78 $354K 126,090
2019-01-23 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award +2,418 9,160
2019-01-23 Korenberg Matthew E EVP,Finance & Strategy and CFO Shares withheld for taxes −713 $111.78 $80K 8,447
2019-01-23 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award +2,230 10,677
2019-01-23 Korenberg Matthew E EVP,Finance & Strategy and CFO Shares withheld for taxes −612 $111.78 $68K 10,065
2019-01-10 Berkman Charles S SVP, Gen. Counsel & Secretary Option exercise +244 $21.92 $5K 37,307
2019-01-10 Berkman Charles S SVP, Gen. Counsel & Secretary Option exercise +1,931 $74.42 $144K 39,238
2019-01-10 Berkman Charles S SVP, Gen. Counsel & Secretary Option exercise +675 $56.26 $38K 39,913
2019-01-10 Berkman Charles S SVP, Gen. Counsel & Secretary Option exercise · Employee Stock Option (right to buy) −244 0
2019-01-10 Berkman Charles S SVP, Gen. Counsel & Secretary Option exercise · Employee Stock Option (right to buy) −675 2,617
2019-01-10 Berkman Charles S SVP, Gen. Counsel & Secretary Option exercise · Employee Stock Option (right to buy) −1,931 0
2019-01-10 HIGGINS JOHN L Chief Executive Officer Option exercise +4,000 $16.14 $65K 89,419

Page 46 of 55 · 1,097 trades